Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Cash from Financing Activities: 2020-2021

Historic Cash from Financing Activities for Design Therapeutics (DSGN) over the last 1 years, with Dec 2021 value amounting to $193,000.

  • Design Therapeutics' Cash from Financing Activities rose 19200.00% to $193,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $379.2 million, marking a year-over-year change of. This contributed to the annual value of $513,000 for FY2024, which is 29.14% down from last year.
  • Per Design Therapeutics' latest filing, its Cash from Financing Activities stood at $193,000 for Q4 2021, which was up 543.33% from $30,000 recorded in Q3 2021.
  • Design Therapeutics' Cash from Financing Activities' 5-year high stood at $379.0 million during Q1 2021, with a 5-year trough of $1,000 in Q4 2020.
  • Moreover, its 2-year median value for Cash from Financing Activities was $111,500 (2021), whereas its average is $70.6 million.
  • Data for Design Therapeutics' Cash from Financing Activities shows a peak YoY spiked of 19,200.00% (in 2021) over the last 5 years.
  • Design Therapeutics' Cash from Financing Activities (Quarterly) stood at $1,000 in 2020, then spiked by 19,200.00% to $193,000 in 2021.
  • Its last three reported values are $193,000 in Q4 2021, $30,000 for Q3 2021, and $5,000 during Q2 2021.